Regulatory Affairs Services
Navigating Global Pharma Regulatory Affairs Success through Masuu Regulatory Affairs Services
Partner with us to streamline your regulatory processes from registration to commercialization of your product with compliance and achieve success with our expert Global Pharma Regulatory Affairs services for seamless compliance.
Our Services
Comprehensive Global Regulatory Affairs Services
Regulatory White Paper Preparation
Pre-submission Meetings
Scientific Package Preparation
Regulatory Strategy and Dossier Filing
Regulatory Compliance & Due Diligence
Regulatory Resources
Regulatory Artificial Intelligence (Ai)
Review, Authoring & Dossier Compilation
Dossier Lifecycle Management
Our Expertise
Comprehensive Global Regulatory Affairs Services
Our Regulatory Affairs Services cover the entire spectrum of regulatory requirements, from the R&D stage through to post-commercialization of your product. We offer comprehensive regulatory support services across various facets of regulatory affairs, including white paper preparation, pre-submission meetings, scientific package preparation, controlled correspondence, submission gap analysis, and dossier compilation with life-cycle management. Regulatory affairs consulting services are designed to ensure compliance and regulatory success at every step.
Trusted Guidance in Regulatory Matters
Benefit from our team’s deep knowledge of guidance’s and expertise in Global Regulatory Affairs, ensuring compliance with complex regulations and maximizing your chances of regulatory success with first cycle approval of your drug product from global health authorities within stipulated timeline. We navigate the complex regulatory landscape, guiding pharmaceutical companies through the intricate processes to facilitate approvals and market access for their products through regulatory support services.
Delivering Results with Confidence
With a proven track record of successful regulatory submissions and approvals, we instill confidence in our clients, demonstrating our ability to navigate regulatory pathways effectively for regulatory affairs consulting services. Our expertise encompasses diverse aspects, including submissions, compliance, strategy development, and liaison with global regulatory authorities.
Customized Strategies for Your Needs
We understand that each client’s and health authorities regulatory requirements are unique. Our regulatory support services team develops tailored regulatory strategies to address specific challenges and maximize the regulatory compliance to navigate the submission for fast track approval.
Ensuring Adherence to Regulations
We offer extensive regulatory affairs services support, encompassing meticulous regulatory document due diligence, audits of manufacturing sites, scientific assessments of submitted dossiers, and planned changes in submissions such as variations, annual reports, renewals, supplements, PADER/PSUR for global health authorities.
Building Trust and Collaboration
Benefit from our established connections and strong relationships with our clients and health authorities. We foster open communication and collaboration, facilitating smoother interactions and faster regulatory processes through our regulatory affairs services.What Our Client’s Say About Us
Frequently Asked Questions
Pharmaceutical regulatory affairs covers the activities required to support product development, regulatory submissions, approvals, commercialization, and ongoing compliance. It can include regulatory strategy, scientific packages, pre-submission interactions, dossier preparation, submission gap analysis, authority correspondence, variations, renewals, post-approval reporting, and lifecycle management across applicable markets.
A regulatory strategy should consider the product’s development stage, intended market, regulatory classification, applicable approval pathway, evidence requirements, submission format, and interactions with the relevant health authority. The strategy can then establish submission milestones, documentation requirements, regulatory risks, and post-approval obligations needed to support commercialization and ongoing compliance.
A pre-submission meeting can be useful when regulatory questions could materially affect the development or submission strategy. Sponsors may use these interactions to obtain authority feedback on areas such as development plans, regulatory pathways, scientific evidence, submission content, or specific technical questions before filing. Preparation should clearly define the questions and supporting background information.
A regulatory dossier contains the information required by the applicable health authority to assess a pharmaceutical product. Depending on the submission and region, it can include administrative information, quality or CMC data, nonclinical information, clinical evidence, labeling, safety information, and supporting documentation. The dossier should follow the applicable submission format and regulatory requirements.
A regulatory submission gap analysis compares the available dossier and supporting evidence against the applicable health authority requirements. The review can identify missing documents, incomplete scientific evidence, inconsistencies, outdated information, or deficiencies in regulatory content. Findings can then be prioritized according to regulatory impact and addressed before submission or during remediation.
Regulatory due diligence is a structured assessment of a product’s regulatory status, documentation, compliance history, approvals, commitments, and potential regulatory risks. It can be used during licensing, acquisitions, partnerships, product transfers, or other strategic decisions. The assessment helps identify documentation gaps, unresolved obligations, compliance concerns, and potential regulatory barriers.
Regulatory strategy determines how a product should progress through the applicable regulatory pathway, including requirements, evidence, milestones, and authority interactions. A regulatory submission is the formal package of documents and data provided to the health authority for a specific regulatory action. Strategy therefore guides the submission approach, while the submission executes that regulatory plan.
Regulatory submissions require ongoing lifecycle management after approval. Post-approval activities can include variations, supplements, annual reports, renewals, safety reporting, regulatory commitments, and updates to approved information. Changes should be assessed for their regulatory impact and incorporated into the relevant submission or documentation according to the applicable health authority requirements.
Regulatory dossier lifecycle management is the controlled maintenance of regulatory documentation throughout a product’s development and commercialization. It includes tracking regulatory changes, updating approved information, managing variations and renewals, maintaining submission records, and incorporating new safety or scientific information. Effective lifecycle management helps keep the regulatory dossier current and consistent with product status.
Regulatory affairs supports global market entry by identifying country-specific regulatory pathways, documentation requirements, submission formats, evidence expectations, and post-approval obligations. A coordinated strategy can help determine which information can be reused or adapted across markets while addressing local requirements. Regulatory planning also supports authority interactions, dossier preparation, submissions, approvals, and subsequent lifecycle activities.